Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) CEO Sells 5,000 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) CEO Jim Brown sold 5,000 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $29.47, for a total transaction of $147,350.00. Following the completion of the transaction, the chief executive officer now directly owns 15,716 shares of the company’s stock, valued at approximately $463,150.52. The trade was a 24.14 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

USANA Health Sciences Price Performance

Shares of USNA opened at $30.86 on Thursday. The business’s fifty day moving average price is $33.20 and its 200 day moving average price is $36.34. USANA Health Sciences, Inc. has a 12-month low of $27.71 and a 12-month high of $50.32. The stock has a market capitalization of $588.10 million, a PE ratio of 10.90, a price-to-earnings-growth ratio of 0.93 and a beta of 0.98.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.49 by $0.15. The company had revenue of $213.61 million during the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. As a group, research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Institutional Investors Weigh In On USANA Health Sciences

Several large investors have recently added to or reduced their stakes in the stock. Barclays PLC boosted its holdings in shares of USANA Health Sciences by 111.9% during the third quarter. Barclays PLC now owns 27,737 shares of the company’s stock valued at $1,052,000 after acquiring an additional 14,647 shares during the period. Geode Capital Management LLC lifted its position in USANA Health Sciences by 4.5% in the 3rd quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock valued at $11,269,000 after purchasing an additional 12,898 shares during the last quarter. State Street Corp lifted its position in USANA Health Sciences by 0.6% in the 3rd quarter. State Street Corp now owns 435,164 shares of the company’s stock valued at $16,501,000 after purchasing an additional 2,782 shares during the last quarter. Nordea Investment Management AB boosted its stake in USANA Health Sciences by 5.7% during the 4th quarter. Nordea Investment Management AB now owns 50,450 shares of the company’s stock valued at $1,814,000 after purchasing an additional 2,723 shares during the period. Finally, Pacer Advisors Inc. grew its position in USANA Health Sciences by 8.8% in the 4th quarter. Pacer Advisors Inc. now owns 592,001 shares of the company’s stock worth $21,247,000 after purchasing an additional 47,745 shares during the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

USNA has been the subject of several research analyst reports. StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. DA Davidson reduced their price target on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research report on Thursday, February 27th. Finally, Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.